Ipsos Healthcare Appoints Jackie Ilacqua Global Head of Syndicated Services & Oncology Portfolio

Thursday, April 18, 2013

Parsippany, NJ – Ipsos Healthcare has announced the appointment of Jackie Ilacqua as Global Head of Syndicated Services. In addition, she retains her existing role as President of Global Oncology, leading the company’s syndicated and custom oncology business around the globe. Ilacqua, who is also a member of the Ipsos Healthcare Board, will oversee and grow these two core elements of the Ipsos Healthcare offering.

Jackie Ilacqua

Ipsos Healthcare’s Syndicated Services include the market-leading Global Oncology Monitor and Global Therapy Monitor portfolios, alongside a range of new services that include social listening, molecular diagnostics, disease-specific ethnography studies and a suite of commercial strategy offerings.

In her 20+ year career, Ilacqua has worked across both ad hoc and syndicated business globally – during which time, she has grown Ipsos’ Global Oncology Monitor from 7 countries to 21, created a range of new products, and worked with virtually every oncology manufacturer, researching almost every type of cancer.

Ipsos Healthcare’s Global Therapy Monitor portfolio will continue to be run by Rhoda Schmuecking – President, Global Therapy Monitors and also a member of the Ipsos Healthcare Board – who will report into Ilacqua. Under Schmuecking’s leadership, the portfolio has expanded into multiple new areas and markets, and now covers more than 20 diseases in 35 countries.

Commented Michael Spedding, CEO of Ipsos Healthcare:

“Our syndicated services are a key strategic priority for Ipsos Healthcare, as is our global oncology portfolio. Jackie brings to this combined role an impressive blend of market research knowledge, healthcare expertise and true strategic flair. She is perfectly placed to lead the charge in adding value to existing services, and extending our portfolio to meet clients’ changing needs.”

Added Ilacqua:

“With patents expiring and budgets being squeezed, pharma and biotech companies are being challenged to achieve the same results with less resource. Syndicated services, either alone or in combination with custom research, are the perfect solution. I’m delighted to take on this key role and create new ways of helping our clients get more for less.”

For more information on this news release please contact:

Jackie Ilacqua
Head of Syndicated Services & President of Global Oncology
Ipsos Healthcare
201.574.8079
jackie.ilacqua@ipsos.com

Michael Spedding
CEO
Ipsos Healthcare
973.216.8537
michael.spedding@ipsos.com

About Ipsos Healthcare’s Syndicated Services

Ipsos Healthcare’s Syndicated Services include the Global Oncology Monitor and Global Therapy Monitors which, together, comprise the industry’s largest portfolio of syndicated patient chart audit data. The suite of global studies tracks usage of treatments across 20+ disease areas, including Oncology, Metabolics, Virology, Autoimmune, Cardiovascular and more. Together, they encompass 4000 physicians reporting on 200,000 patients in 35 markets worldwide. The Syndicated Services portfolio also includes oncology molecular diagnostics, oncology social listening, disease-specific ethnography studies and a suite of commercial strategy offerings.

About Ipsos Healthcare

Ipsos Healthcare is a global specialised practice focusing on research in the pharmaceutical, bio-tech and medical device markets. It is also a leading provider of global syndicated patient chart studies in 35 markets. Operating in over 40 countries, the team of 500 healthcare market research experts, marketers and client-side brand-builders focuses on delivering outcome-oriented research for its clients. Drawing from a broad range of qualitative and quantitative techniques, Ipsos Healthcare offers custom and syndicated research programs to evaluate the motivations, experiences, interactions and influences of stakeholders forming the multi-customer markets that increasingly drive business success in the healthcare industry.

About Ipsos

Ipsos is an independent market research company controlled and managed by research professionals. Founded in France in 1975, Ipsos has grown into a worldwide research group with a strong presence in all key markets. In October 2011 Ipsos completed the acquisition of Synovate. The combination forms the world’s third largest market research company.

With offices in 85 countries, Ipsos delivers insightful expertise across six research specializations: advertising, customer loyalty, marketing, media, public affairs research, and survey management.

Ipsos researchers assess market potential and interpret market trends. They develop and build brands. They help clients build long-term relationships with their customers. They test advertising and study audience responses to various media and they measure public opinion around the globe.

Ipsos has been listed on the Paris Stock Exchange since 1999 and generated global revenues of €1,789 billion (2.300 billion USD) in 2012.


Ipsos Healthcare Appoints Jackie Ilacqua Global Head of Syndicated Services & Oncology Portfolio

Downloads PDF

Press Release

Contact

Jackie Ilacqua
President, Global Oncology
Ipsos Healthcare
+1.201.574.8079
jackie.ilacqua@ipsos.com
Michael Spedding
CEO
Ipsos Healthcare
(973) 216-8537
michael.spedding@ipsos.com